|
HS Code |
110803 |
| Chemical Name | Ethyl p-Aminobenzoate |
| Common Name | Benzocaine |
| Molecular Formula | C9H11NO2 |
| Molecular Weight | 165.19 g/mol |
| Cas Number | 94-09-7 |
| Appearance | White crystalline powder |
| Melting Point | 88-90 °C |
| Solubility In Water | Slightly soluble |
| Boiling Point | 310 °C (decomposes) |
| Odor | Odorless |
| Pka | 2.5 |
| Logp | 2.5 |
| Density | 1.17 g/cm³ |
| Storage Conditions | Store in a cool, dry place |
| Iupac Name | Ethyl 4-aminobenzoate |
As an accredited Ethyl p-Aminobenzoate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ethyl p-Aminobenzoate is packaged in a 100g amber glass bottle, tightly sealed, and labeled with hazard and handling information. |
| Shipping | **Ethyl p-Aminobenzoate** is shipped in tightly sealed containers, protected from light, moisture, and incompatible materials. Shipping must comply with relevant regulations for laboratory chemicals, typically via ground or air in secure packaging. Ensure proper labeling and include Safety Data Sheet (SDS) for safe handling during transit. |
| Storage | Ethyl p-Aminobenzoate should be stored in a tightly closed container, in a cool, dry, well-ventilated area away from incompatible substances such as strong oxidizing agents. It should be kept away from light and heat sources to prevent decomposition. Proper labeling and safe handling procedures are recommended to minimize risk and ensure the chemical’s stability and purity during storage. |
|
Purity 99%: Ethyl p-Aminobenzoate with purity 99% is used in topical anesthetic formulations, where high purity ensures rapid onset of local numbness. Melting point 89–92°C: Ethyl p-Aminobenzoate with melting point 89–92°C is used in pharmaceutical compounding, where precise melting behavior facilitates controlled processing. Stability temperature up to 40°C: Ethyl p-Aminobenzoate with stability temperature up to 40°C is used in medicated ointments, where enhanced thermal stability maintains efficacy during storage. Particle size <50 μm: Ethyl p-Aminobenzoate with particle size less than 50 μm is used in dermatological creams, where fine particle dispersion improves skin absorption. Molecular weight 165.19 g/mol: Ethyl p-Aminobenzoate with molecular weight 165.19 g/mol is used in cosmetic formulations, where optimal molecular sizing promotes uniform application and activity. Water solubility <0.5 g/L: Ethyl p-Aminobenzoate with water solubility less than 0.5 g/L is used in lipophilic drug delivery systems, where low solubility increases formulation stability. Assay ≥98%: Ethyl p-Aminobenzoate with assay ≥98% is used in laboratory research, where high assay accuracy supports reproducible experimental outcomes. Residual solvent <0.1%: Ethyl p-Aminobenzoate with residual solvent content below 0.1% is used in injectable anesthetics, where minimal solvent levels reduce adverse reactions. |
Competitive Ethyl p-Aminobenzoate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Ethyl p-Aminobenzoate, sometimes known in medical circles as benzocaine, isn’t just another name on a pharmacy shelf. Over years working in both academic and clinical settings, I have found its role to reach far beyond a supplementary mention in textbooks. With the chemical formula C9H11NO2, this compound often appears as a white, odorless crystalline powder. At its core, Ethyl p-Aminobenzoate offers targeted numbing, valued mostly for surface procedures or minor discomforts in dentistry and small surgical interventions. Having had conversations with dental professionals and pharmacists, the common consensus is clear: it provides a fast, reliable onset of local anesthesia without the systemic risks typical of stronger injectables.
People usually come across this product in dental gels or topical creams. Its melting point usually ranges a bit over 88°C, giving it enough stability for pharmaceutical compounding. Chemists I’ve spoken with appreciate this property, since it makes the compound workable under gentle heating methods, while pharmacists say they prefer its consistency during long-term storage. Given its chemical makeup, it dissolves nicely in alcohol and ether, but resists breaking down in water, which shapes its uses for skin and mucous membranes instead of deeper injections.
I’ve found Ethyl p-Aminobenzoate often gets grouped in general conversations with lidocaine or procaine, but to call them all the same would be missing the point. Lidocaine, for instance, penetrates membranes more deeply, but it can trigger allergic reactions in a small percentage of patients and tends to come with stricter handling regulations. Ethyl p-Aminobenzoate stands apart because its molecule acts gently—rarely causing systemic toxicity, provided the surface use remains within recommended doses. In my time spent reading case studies and industry literature, incidences of adverse effects are rare unless someone over-applies or uses it in ways not advised by professionals.
Based on my research and interviews with practitioners, many appreciate its almost negligible odor and agreeable taste. For dental settings, this means less discomfort for patients and easier application than alternatives that might carry bitterness or sharp chemical notes. In usability, it allows a clinician to target a sore gumline or minor skin abrasion and give patients relief without sedating the nerves deeper inside tissues. It is worth noting, though, Ethyl p-Aminobenzoate is not suitable for deep-tissue work, nor does it belong in eyes or inside deep puncture wounds. That’s not a limitation—it’s a strength, since its molecule doesn’t pass easily through unbroken skin but works right where surface relief matters most.
While it’s tempting to get wrapped up in numbers—purity percentages, particle sizes, lab standard codes—real-life experience teaches a different lesson. I remember years ago, in a compounding pharmacy, the most important thing wasn’t just hitting some magical 99% purity mark; it was getting a consistent texture and a fast-acting result. Ethyl p-Aminobenzoate's average pharmaceutical sample comes close to these hopes, yielding a fine, smooth powder that disperses evenly in ointments and gels. This quality feeds directly into how reliably it performs. When I spoke to pharmacists about their preferred anesthetic bases, they consistently mentioned they go back to Ethyl p-Aminobenzoate in key situations for its adaptability—not just some theoretical batch report from a factory.
Differences among brands and manufacturers can spark lively debates, too. I’ve sat through more than one seminar where someone argues their favorite brand outperforms another. In practice, once you have a purity above a certain level and a known melting point, distinctions tend to blur. Problems arise only when corners are cut—poor packaging, improper storage, or contamination. The lesson here is direct: An effective product still starts and ends with a reliable supply chain, tight temperature control, and up-to-date chemical analysis. If someone you know invests in a batch of Ethyl p-Aminobenzoate, ask pointed questions about sourcing, batch certificates, and shipping containers before thinking about obscure “premium” claims.
Tracing back the history of surface anesthetics, Ethyl p-Aminobenzoate shows up in pharmacy literature early in the twentieth century. Compared with today’s choices, it might seem old-fashioned, but repeated studies on application at minor wound sites continue even now. Scientific reviews, including those from leading dermatology journals, highlight its safety when used as intended. What sticks with me from reading hundreds of published articles is that, while newer anesthetics keep pushing for faster or deeper results, Ethyl p-Aminobenzoate holds its ground for predictable, localized action.
There’s been gossip in some circles about allergic reactions to local anesthetics—particularly para-aminobenzoic acid derivatives like this one. From what I’ve observed, true allergies to Ethyl p-Aminobenzoate remain rare. Medical professionals are taught to test it in small quantities, especially for someone with lots of allergies, but otherwise, it’s been a quiet and effective tool for decades. Families dealing with mouth sores or children with small abrasions have long relied on topical gels containing it. That kind of trust only comes from reliable experience, not marketing noise.
The most common way people—both professionals and lay users—interact with Ethyl p-Aminobenzoate comes through over-the-counter oral gels. In the dental chair, it eases anxiety by softening the pain of injections, extractions, or accidental cheek bites. In home use, parents and adults alike reach for it as a quick fix for cold sores, canker sores, or sore gums. There’s an ease to its use. All you need is a clean finger or a cotton swab, and direct application right to the affected site. This gets relief to where it’s wanted, sparing unnecessary numbness to the rest of the mouth.
For more clinical situations, like prepping a laceration for stitches or easing the discomfort of superficial burns, nurses and doctors report using topical forms of Ethyl p-Aminobenzoate as a first step before moving to something more powerful if needed. Among its biggest assets has always been minimal risk for systemic absorption, so patients may apply it a few times a day without concern over dangerous accumulation. For the elderly or pregnant women, there is a peace of mind associated with well-understood products. In practice, this means a lot—healthcare choices become clearer and easier.
Comparisons with other “caines” can reveal trade-offs. Lidocaine, the dominant anesthetic in most emergency kits, goes deeper and works on more procedures but is more tightly controlled. As a long-time observer of pharmacy practice, I notice that staff often choose Ethyl p-Aminobenzoate for minor concerns simply because it fits the problem—no extra paperwork, no high-risk warnings on the shelf. In settings where patient history is complicated or reactions to other chemicals are a concern, users point to its long record of safe use as a valuable factor.
Like all medications, Ethyl p-Aminobenzoate isn’t fit for every job. It can soothe surface pain, it won’t fix deep-seated dental infection, nor should it be placed on large, open injuries. As someone who’s seen both correct and incorrect uses, I think education means everything here. Manufacturers supply warning labels, but real knowledge grows from family physicians, pharmacists, and public health educators repeating clear messages about appropriate use. In my experience, confusion only grows when people chase one-size-fits-all answers. Each condition asks for its proper tool, and Ethyl p-Aminobenzoate answers reliably for minor topical needs.
There have been rare reports of methemoglobinemia with massive, inappropriate application of surface anesthetics—including benzocaine types. This isn’t unique to Ethyl p-Aminobenzoate but applies across similar drugs. Having looked at the numbers and case studies, I can say with confidence that proper use almost never leads to danger: apply thinly, avoid broken skin or large surfaces, and stick to recommended intervals. Teaching these habits matters far more than promising a side-effect-free existence.
It’s also worth clearing up that just because a substance is available over the counter, it doesn’t make it trivial or risk-free. That said, the long track record of Ethyl p-Aminobenzoate use—in medical, dental, and even some veterinary settings—gives it a reputation for safety earned the hard way, through repeated trials and public use. I’ve seen many trusted practitioners keep samples on hand for minor emergencies, and the reasons come down to predictability, ease, and familiarity.
One thing I’ve learned from working with pharmaceutical supply teams is how everything begins with sourcing. Quality doesn’t just happen in a lab—it starts with the raw material, how it’s transported, how long it sits, what kind of packaging shields it from heat or contamination. Poor quality can ruin Ethyl p-Aminobenzoate’s reputation almost overnight. Users should look for reliable batch numbers, up-to-date analysis certificates, and packaging that guarantees the compound hasn’t absorbed moisture or altered in transit.
Individual clinics sometimes prefer a certain model—say, a micronized powder for easier mixing, or a slightly coarser variety for ointment forms—but consistent product experience matters more than technical perfection on a chemical grid. Whenever I see practitioners arguing over minor differences, I remind them: tools work best when users know them well, not just because a label claims some special purity or process. Ethyl p-Aminobenzoate’s value comes from knowing it will behave as expected, time and time again, not just from a single lot or shipment.
Over the years, I have followed scientific debates about the future of local anesthetics. Some researchers are after longer durations or higher potency, but longevity and reliability often win out in the marketplace. Ethyl p-Aminobenzoate appears regularly in regulatory reports and review articles because it keeps meeting safety guidelines when used as intended. Its gentle, surface-focused action meets real needs for short procedures and routine discomforts better than some newcomers that promise more but expose users to more risks.
What’s likely to drive change in coming years will not be new molecules alone, but better education and communication about safe applications. Technical guidance grows with better data. More pharmacists are investing in tools that confirm purity on-site and train staff to recognize real from counterfeit or unapproved products. A focus on packaging improvements and clearer instructions will likely help reduce misuse and keep allergic reactions extremely rare.
Walk through any pharmacy aisle, and you’ll see topical gels and ointments offering minor pain or itch relief. Chin up to the cosmetic counter, and the careful observer will spot it in certain sunscreens or after-care lotions, although its use there has faded as new regulations tighten what can go on unbroken skin. Out of all these products, Ethyl p-Aminobenzoate stands out for its consistency, low odor, and fast action. Given its mild taste, children tolerate dental gels better and more willingly accept minor procedures.
In my community, people know what to expect and trust products containing this ingredient for first aid. Teachers keep it for student scrapes. Athletes use it to soothe chafing or mild burns. Its role, then, isn’t just technical—it shapes daily routines, supports confidence in self-care, and complements medical judgment instead of interfering with it. Public health clinics reach for it not just because it “works” but because they can depend on how and when it works.
Many problems arise not from the compound itself but from how it’s sold and used. Good public education can prevent the handful of adverse events seen in medical literature. Practical solutions include clearer packaging overlays stating “surface use only,” pharmacist-led workshops for caregivers about identifying mild versus serious pain, and regular training updates for dental staff and primary care teams. My hope is that, with coordinated communication and up-to-date advice, more people will use Ethyl p-Aminobenzoate safely and effectively.
Another area needing attention is counterfeit or substandard supply. As with any popular product, some vendors may cut corners or mislabel goods to reap higher profits. Users—whether professionals or consumers—should ask for evidence of regulatory compliance from suppliers. Regulators can assist by offering track-and-trace features for pharmacy orders. The most effective way forward is to promote transparency across the entire delivery chain. I have seen clinics be most successful when they invest in sourcing relationships and take time to check that what enters their shelves matches the standard they expect.
Adapting to local demands might call for new delivery forms: dissolvable films, rapid-acting sprays, or precision applicators, each designed for specific scenarios, such as pediatric dentistry, field emergencies, or chronic sore care. Feedback from real users continues to shape these advancements. As new research refines how much, how often, and in what form Ethyl p-Aminobenzoate provides relief, the product stays relevant to everyday health concerns.
Stepping back, Ethyl p-Aminobenzoate represents more than a chemical or a line in a pharmacy inventory. It stands as proof that reliable, focused solutions earn loyalty. In every setting where minor pain relief matters, across decades of use, this compound keeps showing up. Experienced pharmacists reach for it without hesitation when someone describes a child’s sore gum or athlete’s skin irritation. Modern innovation offers new means, but history reminds us—the simplest answers, tested with time and real-world use, carry a value numbers on a datasheet simply can’t match.
Its continued place in medicine results from more than inertia or habit. The molecule fits the need for targeted, surface-specific relief better than most broader solutions on the market. In doing so, it teaches a lesson relevant beyond pharmacy: know the problem, choose the right answer, and never take safety for granted. Practitioners, researchers, and everyday users stay loyal not because of advertising claims, but from seeing the difference firsthand.
As the field of minor pain relief grows more complex, products like Ethyl p-Aminobenzoate remind us to remain grounded in experience. Whether used in a small clinic, at home, or out in the field, its enduring value stands not as a relic, but as a solution tuned to the scale of the everyday problem. More than a label or a chemistry lesson, it remains relevant because it answers the immediate, practical needs of people who seek comfort, safety, and reliability. Watching pharmacy practice evolve, I see this compound’s role not shrinking, but adapting—always with the user’s needs and best interests at heart.